Inflammatory Myofibroblastic Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-08-29
Clinical Trial Update: Treatment With Crizotinib Single Patient Expanded Access IND 134375
This document reports a single-patient expanded-access use of crizotinib for inflammatory myofibroblastic tumor. The entry is no longer avai…